Bormioli Pharma is in continuous expansion. Its strategic importance is testified to by its various different plants scattered across Europe, and by the number of prestigious collaborations it enjoys with many of the most important pharmaceutical companies.
Bormioli Pharma is globally renowned for the quality and degree of innovation of its products. The company currently employs over 900 people, and runs 5 plants specialized in the manufacture of glass and plastic packaging.
Bormioli Pharma offers a huge range of glass packaging for the pharmaceutical market, and stands out for its quality, technological innovation and commercial services. It boasts state-of-the-art manufacturing facilities, including 6 furnaces dedicated to the creation of both tubular and molded glass packaging products.
Our product range is completed by a broad spectrum of plastic packaging solutions for the pharmaceutical, cosmetics and food sectors. This too is based on highly sophisticated materials and technologies that guarantee our ability to satisfy the need for chemical stability, dimensional precision and mechanical resistance... not forgetting practicality and design factors.
In its untiring quest for quality, Bormioli Pharma focuses strongly on personnel programs, implements the strictest manufacturing procedures and constantly invests in technologies and facilities; from clean rooms for preventing particle contamination to increasingly efficient and sophisticated control systems.
All this in order to ensure packaging products that fully comply both with client company specifications and elevated health and hygiene standards. A precise mission lies behind these demanding commitments: to stand by the side of pharmaceutical companies and satisfy every request for improvement and product packaging need.
Building better businesses
Bormioli Pharma is owned by Triton since 2017.
Triton is an international investment firm, founded in 1997. The company seeks to contribute to building better businesses for the longer term through partnership.
Triton invests in medium-sized businesses with management located in Europe that fall within the Industrial, Business Services and Consumer/Health sectors.
Triton funds’ approximately 100 investors include, among others, pension funds, sovereign wealth funds, insurance companies and endowments. Triton includes environmental, social and governance criteria into investment considerations and decision-making processes which help to capture long-term value.
Since its founding, Triton has completed more than 60 investments and supported more than 260 acquisitions.
For more information, please visit: www.triton-partners.com
Bormioli Pharma's product range includes glass and plastic vials, closure systems, containers and accessories for antibiotics, infusions, syrups, drops, pills and reagents. The range is completed by Bormioli's plastic packaging products for the cosmetics and food sectors. As well as constantly expanding and enhancing its standard range of products, Bormioli Pharma also produces customized packaging and develops new materials and innovative solutions.
In the course of its many operational activities, the company keeps a close eye on market evolution and also on environmental issues.
The company is certified to ISO 9001:2008 and ISO 15378. This latter certification guarantees that the activity and organisation of the production sites complies with international Good Manufacturing Practice standards, with reference to primary packaging for medicinal products. Bormioli Pharma has also been awarded certification for compliance with European Directive 93/42 EEC for medical devices . Furthermore the company is registered with international control bodies such as FDA for the United States market, TPP for Canada and SDA for China.